Markets
WBA

Walgreens (WBA) Beats Q2 Earnings, Misses Revenue Estimates - Tale of the Tape

Walgreens (WBA) Beats Q4 Earnings, Misses Revenue Estimates

Are you a frequent visitor to retail drugstores? Then you must have come across at least one of the 8,232 drugstores operated by Walgreens Boots Alliance, Inc. ( WBA ). This Illinois-based company is the first global pharmacy-led, health and wellbeing enterprise.

Currently, Walgreens has a Zacks Rank #4 (Sell) but that could change following its mixed second quarter fiscal 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:

Earnings: The Zacks Consensus Estimate remained steady at 94 cents per share over the last 30 days. Walgreens' adjusted earnings per share of $1.18 beat this estimate by 25.5%.

Revenues: Walgreens posted revenues of $26.6 billion and missed the Zacks Consensus Estimate for revenues of $27.7 billion.

Key Stats : Revenue from the Retail Pharmacy USA division increased 7.4% to $21 billion, while the Retail Pharmacy International division delivered sales of $2 billion. On the other hand, the Pharmaceutical Wholesale division delivered sales of $3.9 billion. Moreover, Walgreens filled 224 million prescriptions (including immunizations) on a 30-day adjusted basis in the quarter, reflecting an increase of 4.8 % over second quarter of fiscal 2014.

Major Factors : Currently, Walgreens aims at improving its global business performance, reinvesting in the stores of the Retail Pharmacy USA division to improve the customer experience and expand retail margins and lastly restructuring its cost base, particularly in the U.S. Through these efforts, Walgreens is determined to become a leading innovative, pharmacy-led health care.

Stock Price : Following the earnings release, share prices did not show any movement in the pre-market trading session.

Check back later for our full write up on this Walgreens earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

WALGREENS BAI (WBA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

WBA

Other Topics

Earnings Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More